---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-139069"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2022-05-04T23:59:59+00:00"
generated_at: "2026-06-26T00:54:19.878018+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tarsus prices upsized $75.6M public offering of 5.6M shares at $13.50/share

## Summary
- Priced 5,600,000 shares of common stock at $13.50 per share for gross proceeds of $75.6M.
- Underwriters granted 30-day option to purchase up to 840,000 additional shares.
- Net proceeds expected to be ~$70.6M after underwriting discounts and expenses.
- Offering led by BofA Securities, Jefferies, Barclays, and Raymond James as joint book-runners.
- Closing expected on May 5, 2022, subject to customary conditions.

## SEC filing metadata
- accession: 0001193125-22-139069
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2022-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000119312522139069/0001193125-22-139069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000119312522139069/d333422d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-139069
- JSON: https://secwatch.observer/filing/0001193125-22-139069.json
- Plain text: https://secwatch.observer/filing/0001193125-22-139069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.